• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    ADA Reveals R&D Priorities for Obesity Blockbusters

    BIOSPACE

    Coalition Calls For Protection Of Nation’s Health Infrastructure

    GLOBENEWSWIRE

    City of Hope diabetes experts present innovative research at ADA conference.

    BUSINESSWIRE

    Veru Presents Safety and Body Composition Data at ADA`s 84th Scientific Sessions

    GLOBENEWSWIRE

    Corcept Presents CATALYST Trial Results at ADA Scientific Sessions

    GLOBENEWSWIRE

    Diabetes Institute Announces Breakthrough Transplantation For Type 1 Diabetes

    ACCESSWIRE

    Sun Pharma`s Utreglutide Shows Weight Loss Efficacy at ADA 84th Session

    PR NEWSWIRE

    Gan & Lee Announces Progress on Diabetes and Obesity Treatments at ADA 84th

    PR NEWSWIRE

    The American Diabetes Association Names Winners of Diabetes Innovation Challenge

    PR NEWSWIRE

    ADA Highlights Innovations in Drug Therapies for Obesity

    PR NEWSWIRE

    Tandem Mobi Improves Quality of Life in Type 1 Diabetes ADA Scientific Sessions

    BUSINESSWIRE

    INHALE-3 Inhaled Insulin vs. Usual Care T1D ADA 84th Session

    GLOBENEWSWIRE

    Sciwind to Highlight Positive Results for Ecnoglutide and Amylin Analogs

    PR NEWSWIRE

    BioAge Labs Presents Preclinical Data for Azelaprag in Obesity

    BUSINESSWIRE

    OrsoBio Presents Phase 1 and Preclinical Data at ADA 84th Sessions

    BUSINESSWIRE

    Terns Pharmaceuticals Preclinical Data TERN-501 GLP-1R Agonist ADA 84th Session

    GLOBENEWSWIRE

    Fractyl Presents Rejuva® Obesity Preclinical Data At ADA 2024

    GLOBENEWSWIRE

    GlucoTrack Abstract At ADA Scientific Sessions

    GLOBENEWSWIRE

    Sanofi Canada continues to invest in modern diabetes research

    NEWSWIRE

    Lilly`s SURPASS-2 results published in The NEJM

    PRESS RELEASE

    Akero Presents at the ADA’s 81st Scientific Sessions

    GLOBENEWSWIRE

    Lexicon Announces Symposium at the ADA 81st Scientific Sessions

    GLOBENEWSWIRE

    Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon at ADA 2021

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.